CEL-SCI Corporation: Clinical Trials

1 trial sponsored by CEL-SCI Corporation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow CEL-SCI Corporation: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity
LI, Cyclophosphamide, Indomethacin - Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Soft Palate
Phase 3CompletedCEL-SCI Corporation9282010-12-012022-08-19

Conditions studied

Squamous Cell Carcinoma of Head and Neck (1)

Interventions

Cisplatin (1)  ·  Cyclophosphamide (1)  ·  Geritol (1)  ·  Indomethacin (1)  ·  Injections (1)  ·  Radiotherapy (1)  ·  Surgical Procedures, Operative (1)  ·  Zinc (1)

Countries

Austria (1)  ·  Belarus (1)  ·  Bosnia and Herzegovina (1)  ·  Canada (1)  ·  Croatia (1)  ·  France (1)  ·  Hungary (1)  ·  India (1)  ·  Israel (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  Serbia (1)

Top investigators

Eyal Talor, PhD (1)

Results publications

PMID 40191245, PMID 42537452